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From 1999 through 2005, the incidence of listeriosis 
in France declined from 4.5 to 3.5 cases/million persons. 
In 2006, it increased to 4.7 cases/million persons. Exten-
sive epidemiologic investigations of clusters in France have 
ruled out the occurrence of large foodborne disease out-
breaks. In addition, no increase has occurred in pregnancy-
associated cases or among persons <60 years of age who 
have no underlying disease. Increases have occurred main-
ly among persons >60 years of age and appear to be most 
pronounced for persons >70 years of age. In 8 other Euro-
pean countries, the incidence of listeriosis has increased, 
or remained relatively high, since 2000. As in France, these 
increases cannot be attributed to foodborne outbreaks, and 
no increase has been observed in pregnancy-associated 
cases. European countries appear to be experiencing an 
increased incidence of listeriosis among persons >60 years 
of age. The cause of this selective increased incidence is 
unknown.
S
urveillance methods for listeriosis vary across Europe 
(1). Reported incidence of listeriosis ranged from 0 to 
7.5 cases/million persons in 2002; the highest rates were 
reported from countries with statutory reporting of cases 
and surveillance through a national reference laboratory 
(1). In recent years, interest in developing a European sur-
veillance network for listeriosis has led to enhanced sur-
veillance activities in several countries and has generally 
heightened awareness of the public health importance of 
Listeria monocytogenes. The epidemiologic picture that has 
emerged from recent national surveillance reports suggests 
that rates of listeriosis across Europe have been increasing 
or have remained stable at relatively high levels (2). In con-
trast, the incidence of listeriosis in France declined from 
4.5 cases/million persons during 1999–2000 to ≈3.5 cases/
million during 2001–2003 (3).
In 2006, however, France reported an increase in the 
incidence of listeriosis. This increase appears to share 
many of the epidemiologic features of recent increases in 
other European countries. We describe the emerging epide-
miology of listeriosis in France and discuss it in the context 
of recent increases in other European countries.
Methods
Data Collection from France
Surveillance of human listeriosis in France has been 
conducted with consistent methods since 1999 (4). These 
methods include mandatory reporting of cases (monitored 
by Institut de Veille Sanitaire [InVS]) and voluntary sub-
mission of L. monocytogenes strains to the National Refer-
ence Center for Listeria, Institut Pasteur, Paris (NRC). By 
using these complementary approaches, information about 
clinical data, demographic data, and food consumption can 
be collected for each patient. In addition, temporal trends 
in disease occurrence can be tracked, and possible common 
sources of exposure can be identiﬁ  ed among cases in clus-
ters detected by NRC.
Deﬁ  nitions
A case of listeriosis was deﬁ  ned by isolation of L. 
monocytogenes from a patient with a clinically compatible 
illness. A case is considered maternal/neonatal when it in-
volves a pregnant woman, a miscarriage, a stillbirth, or a 
newborn <1 month of age. L. monocytogenes isolated from 
both a pregnant woman and her newborn child is counted 
as a single case. If a case ﬁ  ts none of these groups, it is 
considered not maternal/neonatal. Patients are considered 
to be at risk if they have an underlying pathologic condition 
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that weakens their immune system, such as cancer, blood 
malignancy, organ transplant, chronic hemodialysis, liver 
failure, diabetes, HIV, or treatment with cytolytic or cor-
ticosteroid immunosuppressants. A cluster was deﬁ  ned as 
the occurrence of at least 3 listeriosis cases that involved 
strains of the same pulsovar over a period of 1) 14 weeks 
during January 2000–July 2006 or 2) 6 weeks after July 
2006. Cases not belonging to a cluster were deﬁ  ned as spo-
radic cases.
Mandatory reporting includes submission of case-relat-
ed information on a standard report form. This form includes 
information such as the patient’s district of residence, pa-
tient’s age, the clinical form of disease, the possible exis-
tence of an underlying illness, and whether the patient died 
before follow-up. A standard questionnaire is administered 
in person or by telephone to ascertain food items consumed 
in the 2 months before onset of illness, including food items 
previously identiﬁ  ed as vehicles in outbreaks and foods that 
have been previously found to be contaminated by L. mono-
cytogenes and typically consumed uncooked. Answers are 
entered into a food-exposure database.
Analysis of Strains by NRC
Listeria isolates from patients and foods referred to 
NRC were conﬁ  rmed with API Listeria (bioMérieux, Mar-
cy l’Etoile, France) and serotyped by the classic technique 
until January 2005 (5) and by multiplex PCR (6) since Feb-
ruary 2005. According to our experience, PCR group fully 
corresponds to the 4 major serovars that cause human dis-
ease. Ongoing subtyping was conducted by DNA macrore-
striction proﬁ  les analysis (pulsed-ﬁ  eld gel electrophoresis) 
according to standard protocols (7). Isolates with indistin-
guishable Apa1 and Asc1 DNA macrorestriction proﬁ  les, 
ﬁ  rst based on visual comparison of banding patterns (since 
2006 by using BioNumerics 4.5 software [Applied Maths 
Saint-Martens-Latem, Belgium]), were considered to be 
the same pulsovar. Detected clusters were reported to InVS 
for investigation (3).
Data Analysis
Data analysis was performed with Epi-Info version 
6.04 (Centers for Diseases Control and Prevention, Atlanta, 
GA, USA). Incidence rate ratios (RRs) were calculated with 
Stata version 8.2 (StatCorp, College Station, TX, USA). 
For the data from France, we compared incidence rates in 
2006 and 2007 with the mean incidence over the precedent 
5-year period (2001–2005). To estimate the incidence data 
for 2007 by extrapolation of the incidence observed from 
January to June 2007, we multiplied the incidence from 
January to June by a factor of 1.2, which represents the 
mean annual multiplier (annual cases/cases January–June) 
observed from 2001 through 2006.
Data from Europe
We conducted an Internet search for surveillance data 
from the institutes in charge of infectious disease surveil-
lance in Western European countries. We also reviewed ar-
ticles published on listeriosis trends in European countries 
with data for 2000–2006.
Results
Data from France
Epidemiologic Characteristics
The annual incidence of listeriosis in France decreased 
in 2001 (Table 1) and stabilized until 2005 at ≈3.5 cases/
million persons. In 2006, the incidence increased to 4.7 
cases/million persons. In 2007, 159 cases were reported 
from January through June, which corresponds to an es-
timated incidence of 5.6 cases/million persons. For the 
6-month period from January through June, the incidence 
of listeriosis increased by 46% in 2006 and 2007 compared 
with incidence during 2001–2005 (RR 1.4; 95% conﬁ  dence 
interval [CI] 1.2–1.6; p<0.001).
The increased incidence of listeriosis in 2006–2007 
over that of 2001–2005 was mainly due to a rise in cases in 
persons >60 years of age (+51%; RR 1.6; 95% CI 1.4–1.8; 
p<0.001) and was most pronounced in those >75 years of 
age (+58%; RR 1.7; 95% CI 1.4–2.1; p<0.001) (Figure 1). 
This increase was observed in persons >60 years of age, 
regardless of whether they had a recognized underlying 
condition. The mortality rates among these cases did not 
increase. From 2001–2005 to 2006 and 2007, there was a 
larger overall increase in bacteremia cases (+67%) than in 
central nervous system cases (+35%).
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Table 1. Incidence and characteristics of cases of listeriosis by year, France  
Characteristic 1999 2000 2001 2002 2003 2004 2005 2006
No. cases reported   269 263 188 220 209 236 221 290
Incidence/1 million inhabitants  4.5 4.4 3.1 3.6 3.4 3.8 3.5 4.6
Clinical form 
 Maternal/neonatal  67 64 44 55 47 49 39 36
 Not  maternal/neonatal  202 199 144 165 162 187 182 254
 Bacteriema  122 110 85 89 100 124 115 171
  Central nervous system infection  65 73 51 67 54 53 60 65
 Focal  infection  15 16 8 9 8 10 7 18RESEARCH
The regional distribution of cases did not differ sig-
niﬁ  cantly from 1 region to another during 2006 and 2007 
versus during 2001–2005. The increase was similar for 
sporadic cases and cluster-associated cases (Table 2). A 
seasonal effect, with an increase of cases during summer, 
was observed in 2006, as in preceding years. However, in-
formation about food consumption of patients >60 years of 
age showed that a decrease in consumption of foods con-
sidered to pose a risk for listeriosis occurred in 2006–2007 
compared with 2001–2005.
For persons <60 years of age, a 32% increase was 
observed only in patients with an underlying condition 
that increased their risk for listeriosis (Figure 2), particu-
larly patients with leukemia (Figure 3). The incidence of 
maternal/neonatal cases of listeriosis has decreased con-
tinuously from 1999 to 2006, with the same trend in the 
ﬁ  rst half of 2007. In 2006, maternal/neonatal cases repre-
sented 12% of cases.
Strains Analysis
In 2006, NRC received 280 L. monocytogenes strains, 
which accounted for 96.5% of cases reported to InVS. The 
distribution of strains by serovar/PCR group did not change 
from 2001 through 2006 (Table 3). The most common sero-
var was 4b, which accounted for half of all strains. Analysis 
of PCR group for strains received during the ﬁ  rst 6 months 
in 2007 shows the same results in terms of distribution. As 
in previous years (3), serovar 4b was predominant among 
maternal/neonatal cases and central nervous system infec-
tion cases and more frequent than among bacteremia cases 
(Table 4).
Cluster Detection and Investigations
In 2006, 102 pulsovars were identiﬁ  ed among the 280 
isolates, with 1–30 isolates/pulsovar (Table 5). Pulsed-ﬁ  eld 
gel electrophoresis analysis identiﬁ  ed 11 clusters: 9 involv-
ing strains of PCR group IVb and 2 of PCR group IIa (Table 
5). Results of intensive epidemiologic investigation did not 
show any cluster suggestive of common-source outbreaks. 
In 1 cluster involving 14 cases, an L. monocytogenes strain 
of the case-associated pulsovar was identiﬁ  ed in a sheep 
raw milk cheese that had been consumed by 3 patients but 
not by the other patients in the cluster. The proportion of 
strains related to a cluster in 2006 (34%) was similar to that 
in 2003–2005 (35%) (Table 2).
Data from Europe
Complete annual incidence data from 2000 through 
2006 were available for 5 European countries (Table 6). 
In 2000, the median incidence was 4.7 cases/million per-
sons (range 1.9–7.5 cases/million persons); in 2006, it was 
6.3 cases/million persons (range 3.5–10.3 cases/million 
persons) in these countries. Increases were observed for 
Belgium, Denmark, England, Wales, and Finland. In Swe-
den, the incidence decreased during 2000–2006. However, 
the incidence in Sweden was already high in 2000–2001 
(5.9–7.5 cases/million persons). Incidence data for at least 
5 years during this period were also available for Germany, 
the Netherlands, and Switzerland. They all observed in-
creases over this period.
In England and Wales, Gillespie et al. compared 2 pe-
riods: 1990–2000 and 2001–2004 (8). They showed that 
the increase resulted from a rise in sporadic cases, predomi-
nantly in patients >60 years of age. The increase was inde-
pendent of sex, ethnicity, or economic status and occurred 
in most regions of England and Wales. The proportion of 
serovar 4b and 1/2 isolates and the proportion of persons 
with underlying illness did not change during this period. 
The proportion of bacteremic patients >60 years of age in-
creased signiﬁ  cantly during 2001–2004 versus 1990–2000 
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Figure 1. Trends of non–maternal/
neonatal listeriosis by age, France, 
January 1, 2006–June 30, 2007, 
versus January 1, 2001–December 
31, 2005.
Table 2. Clusters of listeriosis, cluster-associated cases, and sporadic cases, France, 2000–2006 
Characteristic 2000 2001 2002 2003 2004 2005 2006
No. clusters detected  9 4 10 11 13 11 11
No. cases belonging to a cluster  53 21 70 78 88 65 98
No. sporadic cases  210 167 150 131 148 156 192 Increasing Incidence of Listeriosis, France
(85% vs. 76%); after 2000, the risk among persons >70 
years of age was higher than that for persons 60–69 years 
of age. During the periods compared by Gillespie et al., the 
incidence of maternal/neonatal cases did not change.
In Germany, surveillance data showed a continuous 
increase of cases since 2001, when the national reporting 
system was introduced. A particularly steep increase was 
observed in 2005, when the number of cases increased by 
72%. Analyzing this increase, Koch and Stark reported 
that temporal and spatial distribution of cases did not show 
any clusters suggestive of local outbreaks (9). From 2001 
through 2005, the number of cases in those >60 years of 
age increased by a factor of 2.6. Among persons >80 years 
of age, almost 4 times as many cases were reported in 2005 
as in 2001. In the same period, the annual number of mater-
nal/neonatal cases did not change.
In the Netherlands, until 2005, information was based 
on data from 15 regional public health laboratories that 
cover an estimated 44% of the population and from the 
Netherlands Reference Laboratory for Bacterial Meningi-
tis, which receives isolates from patients with meningitis or 
septicemia. According to these data, the annual incidence 
of listeriosis had been stable until 2002 at ≈2 cases/mil-
lion persons and has increased since 2003 to ≈3 cases/mil-
lion persons (10). Since 2005, an active surveillance that 
involved all laboratories has been implemented. Cases re-
ported by Doorduyn et al. in 2005 (10) corresponded to an 
incidence of 5.6/million persons (Table 6). Although this 
increase may have resulted from the strengthening of list-
eriosis surveillance, the authors do not rule out a genuine 
recent increase in the number of cases.
In Switzerland, an increase has been observed since 
2004. In 2005, an outbreak involving 12 cases (16% of cas-
es reported in 2005) was linked to consumption of a cheese, 
accounting only for a small part of the upsurge (11). In 
2006, the incidence remained high (9.1/million persons), 
although no common-source outbreak was identiﬁ  ed.
In Denmark, an increase since 2004 was caused by 
various subtypes of L. monocytogenes; this increase was 
likely not the consequence of a single outbreak (12). This 
increase involved septicemia cases but not meningitis cas-
es. A further increase was observed in 2006, leading to an 
incidence of 10.3 cases/million persons.
In Finland, an increase has been observed since 2003. 
Clusters are detected by routine serogenotyping of strains. 
In 2003–2004, 2 clusters with 7 cases each were investi-
gated. In 1 cluster, food histories implicated cold ﬁ  sh prod-
ucts (13). Clinical and demographic characteristics of cases 
occurring in 2003–2004 and those occurring in 1999–2000 
did not differ.
In Belgium, the incidence has increased since 2003 
and reached a peak of 8.6 cases/million persons in 2004 
(14). The large increase in 2004 was mainly caused by in-
creasing cases in the Flemish community, and the propor-
tion of isolates of serovar 1/2 was unusually high (68%). 
Therefore, the occurrence of a common-source outbreak in 
2004 cannot be ruled out.
Discussion
Surveillance data in France show an upsurge in human 
listeriosis cases in 2006; this increase was conﬁ  rmed in Jan-
uary–June 2007 such that the annual incidence is now at its 
highest level since 1998, when mandatory reporting was in-
troduced. This upsurge is due to an increase among persons 
>60 years of age who were not pregnant and among persons 
<60 years of age who had a predisposing medical condition.
The methods and conditions of listeriosis surveillance 
in France have remained unchanged since 1998, and the 
sensitivity of the mandatory reporting system is high (15). 
In the 1990s, large outbreaks of listeriosis increased aware-
ness among physicians and microbiologists. Because no 
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Figure 2. Trends of non–maternal/neonatal listeriosis by presence 
of underlying disease and age of patients, France, January 1, 
1999–June 30, 2007. (Data for 2007 are estimated.)
Figure 3. Trends (no. cases 
of listeriosis/y) by underlying 
medical condition, France, 
January 1, 1999–June 30, 
2007. RESEARCH
large outbreaks occurred since 2000, this upsurge is most 
likely not the result of better reporting or raised diagnostic 
awareness. The increase of bacteremic cases could be an 
artifact caused by higher hospitalization rates among the el-
derly, increased frequency of performing blood cultures, or 
increased sensitivity of the blood-culturing systems. How-
ever, from 2005 through 2006, for persons >60 years of age, 
the incidence of listeriosis jumped 39%, the hospitalization 
rates increased <1%, and data from the national insurance 
scheme showed a 20% reduction in blood cultures. Because 
instrumented blood culture systems have been used in hos-
pitals for several years with no demonstrated improvement 
in the sensitivity of detecting L. monocytogenes, the in-
crease of bacteremic infections does not appear to be due to 
diagnostic practices.
In 2006, the proportion of cases related to clusters re-
mained stable; the clusters did not account for the upsurge 
in incidence. Also, multiple L. monocytogenes strains were 
responsible for the increase in cases. Because of the above 
reasons, the increase in incidence in France is unlikely to 
be due to a common-source outbreak.
In several European countries, similar trends of in-
creasing listeriosis case numbers have been observed. For 
countries with a long history of listeriosis surveillance, 
such as England, Wales, Switzerland, and Denmark, the 
observed upsurge is likely genuine. But even for countries 
with recently introduced or strengthened listeriosis surveil-
lance systems, such as the Netherlands and Germany, the 
observed upsurge is not attributed to a surveillance artifact. 
The upsurge is due to an increase in cases in the same pa-
tient groups. 
In France, Germany, England, and Wales, the increased 
incidence occurred predominantly in patients >60 years of 
age. The number of maternal/neonatal cases is declining in 
all countries. Clusters suspected or conﬁ  rmed to represent 
common-source outbreaks contributed to the increased in-
cidence in some countries, such as in Switzerland in 2005, 
in northeast England in 2003, in Finland in 2003–2004, and 
possibly the Netherlands and Belgium in 2004. However, 
in none of these countries did these clusters account for the 
upsurge in incidence.
Many of these same epidemiologic features may also 
be occurring in the United States, where a decline in the 
incidence of listeriosis from 1996 to 2003 was reported on 
FoodNet websites (16). The incidence of listeriosis declined 
from 4.1 to 2.3/million persons from 1996 to 2003; the per-
centage of maternal/neonatal cases dropped from 15% to 
11% during this period. After dropping to a record low in-
cidence of 2.7 cases/million persons in 2004, the incidence 
of listeriosis cases reported on FoodNet websites increased 
to 3.0 cases/million persons in 2005 and 3.1 cases/million 
in 2006 (17).
The reasons for the increased incidence remain un-
clear. The incidence of listeriosis in France decreased 
substantially from 1987 through 1997 because of control 
measures implemented by the food industry in response 
to several large outbreaks (15). After mandatory reporting 
was implemented, incidence further declined from 4.5 cas-
es/million persons during 1999–2000 to ≈3.5 cases/million 
persons during 2001–2003. As this reduction concerned all 
population groups (regardless of whether they were target 
groups for food recommendations), this further decline was 
essentially attributed to a reduction in exposure to contami-
nated food products (15). We are not aware of any changes 
in the control measures used by the food industry that could 
have increased exposure to contaminated foods in 2006 
and 2007. However, in spite of these control measures, we 
cannot rule out that common food stuffs have been more 
frequently or more heavily contaminated with L. monocy-
togenes in the past 2 years (2006–2007).
Concerned by the large amount of disease attributable 
to hypertension-related conditions, in 2002, the French Food 
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Table 3. Distribution of strains of Listeria monocytogenes isolated from human case-patients by serovar, by year 
Characteristic 1999 2000 2001 2002 2003 2004 2005 2006 2007*
No. of strains  240 222 186 202 197 233 212 280 151
Serovar 1/2a, %  27 33 33 22 26 30 24 29 27
Serovar 1/2b, %  20 16 22 18 22 11 17 17 15
Serovar 1/2c, %  5 3 3 4 5 4 3 4 4
Serovar 4b, %  48 48 42 55 47 55 56 50 54
Other serovar, %  <1 0 0 <1 0 0 0 <1 <1
*Through Jun 30. 
Table 4. Distribution of Listeria monocytogenes strains isolated in 2006 from human case-patients, by serovar and clinical forms 
Characteristic No. (%) 1/2a  No. (%) 1/2b  No. (%) 1/2c No. (%) 4b  No. (%) other  Total no. 
Not maternal/neonatal  76 (31)  43 (18)  11 (4)  115 (47)  1 (<1)  246
Central nervous system infection  13 (24)  9 (16)  2 (4)  30 (54)  1 (2)  55
Bacteremia 54 (31)  31 (18)  9 (5)  81 (46)  0 (0)  175
Focal infections  9 (56)  3 (19)  0 (0)  4 (25)  0 (0)  16
Maternal/neonatal  4 (12)  6 (18)  0 (0)  24 (70)  0 (0)  34
Total 80 (29)  49 (17)  11 (4)  139 (50)  1 (<1)  280 Increasing Incidence of Listeriosis, France
Safety Agency recommended a 20% reduction in average 
salt intake spread over 5 years (18). Consequently, the food 
industry reduced the salt content of selected products, such 
as ready-to-eat meat products. Evidence from routine food 
safety investigations indicates that a substantial proportion 
of ready-to-eat products, such as meat and ﬁ  sh products, may 
be contaminated by L. monocytogenes (15). The recently re-
duced salt content in some of these products, if contaminat-
ed, may have contributed to the growth of the organism and 
increased the likelihood of infection when the products were 
consumed by susceptible persons. To verify this hypothesis, 
surveys to determine not only the frequency but also the level 
of contamination by L. monocytogenes of these ready-to-eat 
food stuffs were initiated in 2008. 
In France, we also observed an absolute and relative 
increase in patients with hematologic malignancies. Im-
proved treatment has likely resulted in an increased number 
of patients surviving longer with these malignancies. Nev-
ertheless, we are not aware of a sudden and recent increase 
in the number of these patients that could explain the up-
surge. Further investigations are needed to assess whether 
changes in treatments for these patients may have contrib-
uted to an increased susceptibility for illness.
Conclusion
The epidemiology of listeriosis in Europe is changing; 
the incidence is increasing, and the distribution of cases is 
shifting, primarily affecting elderly persons and those with 
predisposing medical conditions. The absence of large out-
breaks suggests that there may be increasing exposure to 
foods that have sporadic or low-level Listeria contamina-
tion and that have some ability to support growth of List-
eria organisms. The relative contributions of host and envi-
ronmental factors need further study.
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